Trials / Recruiting
RecruitingNCT04487249
Trial of Vision Therapy for Intermittent Exotropia
A Pilot Randomized Trial Evaluating Short-Term Effectiveness of Vision Therapy in Children With Intermittent Exotropia
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (estimated)
- Sponsor
- Southern California College of Optometry at Marshall B. Ketchum University · Academic / Other
- Sex
- All
- Age
- 8 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this randomized trial comparing vision therapy to observation is to determine the short-term effectiveness of vision therapy on distance intermittent exotropia control. The results will help determine whether to proceed to a full-scale, long-term randomized trial.
Detailed description
Vision therapy (VT) is a commonly prescribed treatment for children with intermittent exotropia (IXT). The effectiveness of VT as a treatment modality for children with IXT is unknown because previous studies have largely limited observational or retrospective case series without comparison groups. The objective of this multi-centered pilot randomized trial of VT for IXT compared to observation is to 1) determine the short-term effectiveness of VT on distance intermittent exotropia and 2) determine the feasibility of recruitment and retention of children aged 8 to 16 years old with IXT to participate in a randomized trial of 20 weeks of in-office VT. The results of this trial will provide the needed information to plan and conduct a large-scale randomized trial to determine short-term and long-term effectiveness of VT for IXT in children, with the full-scale randomized trial helping to fill in the gaps in scientific knowledge concerning VT as a treatment for IXT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Vision Therapy | 20 consecutive weeks of office-based vision therapy with home therapy that aim to improve the participant's vergence skills, accommodative skills, and sensory fusion. |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2020-07-27
- Last updated
- 2025-03-05
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04487249. Inclusion in this directory is not an endorsement.